Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 1
2002 1
2003 3
2005 1
2006 1
2007 3
2008 3
2010 2
2011 3
2012 5
2014 4
2015 4
2016 4
2017 4
2018 4
2019 5
2020 6
2021 2
2022 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
[The ATTR-ACT trial].
Rapezzi C, Gagliardi C, Milandri A. Rapezzi C, et al. Among authors: milandri a. G Ital Cardiol (Rome). 2019 Jun;20(6):335-337. doi: 10.1714/3165.31465. G Ital Cardiol (Rome). 2019. PMID: 31184318 Italian. No abstract available.
Electrocardiographic abnormalities in patients with cardiomyopathies.
Aimo A, Milandri A, Barison A, Pezzato A, Morfino P, Vergaro G, Merlo M, Argirò A, Olivotto I, Emdin M, Finocchiaro G, Sinagra G, Elliott P, Rapezzi C. Aimo A, et al. Among authors: milandri a. Heart Fail Rev. 2024 Jan;29(1):151-164. doi: 10.1007/s10741-023-10358-7. Epub 2023 Oct 17. Heart Fail Rev. 2024. PMID: 37848591 Free PMC article. Review.
A new therapy for transthyretin amyloidosis, no longer an orphan condition.
Quarta CC, Tinuper AL, Milandri A, Gagliardi C, Caponeti G, Rapezzi C. Quarta CC, et al. Among authors: milandri a. Eur Heart J Suppl. 2020 Jun;22(Suppl E):E125-E131. doi: 10.1093/eurheartj/suaa077. Epub 2020 Apr 2. Eur Heart J Suppl. 2020. PMID: 32523456 Free PMC article.
Cardiac amyloidosis: the great pretender.
Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I, Salvi F, Maurer MS. Rapezzi C, et al. Among authors: milandri a. Heart Fail Rev. 2015 Mar;20(2):117-24. doi: 10.1007/s10741-015-9480-0. Heart Fail Rev. 2015. PMID: 25758359 Review.
Cardiac involvement in hereditary-transthyretin related amyloidosis.
Rapezzi C, Longhi S, Milandri A, Lorenzini M, Gagliardi C, Gallelli I, Leone O, Quarta CC. Rapezzi C, et al. Among authors: milandri a. Amyloid. 2012 Jun;19 Suppl 1:16-21. doi: 10.3109/13506129.2012.673185. Epub 2012 Apr 12. Amyloid. 2012. PMID: 22494034 Review.
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry.
Lopes LR, Losi MA, Sheikh N, Laroche C, Charron P, Gimeno J, Kaski JP, Maggioni AP, Tavazzi L, Arbustini E, Brito D, Celutkiene J, Hagege A, Linhart A, Mogensen J, Garcia-Pinilla JM, Ripoll-Vera T, Seggewiss H, Villacorta E, Caforio A, Elliott PM; Cardiomyopathy Registry Investigators Group. Lopes LR, et al. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):42-53. doi: 10.1093/ehjqcco/qcac006. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 35138368 Free PMC article.
54 results